NASDAQ:HCWB
HCW Biologics Inc. Stock News
$1.10
+0 (+0%)
At Close: May 17, 2024
HCW Biologics Inc (NASDAQ:HCWB) Short Interest Update
06:18pm, Thursday, 18'th Nov 2021 Dakota Financial News
HCW Biologics Inc (NASDAQ:HCWB) was the recipient of a large growth in short interest in October. As of October 29th, there was short interest totalling 155,400 shares, a growth of 60.0% from the October 14th total of 97,100 shares. Approximately 1.3% of the companys shares are short sold. Based on an average daily volume of []
Good Penny Stocks to Buy Right Now? 3 to Watch in November
01:17pm, Thursday, 28'th Oct 2021
Are these penny stocks worth buying right now? The post Good Penny Stocks to Buy Right Now?
Making a Penny Stocks Watchlist? Don't Forget These 3 Small-Caps
12:37pm, Tuesday, 19'th Oct 2021
Three penny stocks that could be worth watching in the second half of October The post Making a Penny Stocks Watchlist? Don't Forget These 3 Small-Caps appeared first on Penny Stocks to Buy, Picks, Ne
Lead Drug Candidate Engineered Using Tissue FactOr-Based FusIon (TOBI™) Platform
TOBI™ Discovery Platform Creates GMP-Scale Heteromeric Fusion Protein Complexes (HFPCs) That Solve Issues with Multi-Signal Receptor Engagement on Immune Cells
HCW Biologics Reports Second Quarter Financial Results and Recent Business Highlights
07:10am, Friday, 13'th Aug 2021
MIRAMAR, Fla., Aug. 13, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), an innovative, biopharmaceutical company focused on discovering and developing novel immunothera
HCW Biologics Inc. Announces Closing of $56.0 Million Initial Public Offering
04:05pm, Thursday, 22'nd Jul 2021
MIRAMAR, Fla., July 22, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (NASDAQ:HCWB) (the "Company"), an innovative preclinical stage biopharmaceutical company focused on discovering and developing novel
